BCAX NASDAQ
Bicara Therapeutics Inc. Common Stock
1W: +0.9%
1M: -11.8%
3M: +34.6%
YTD: +27.2%
1Y: +38.6%
$21.68
+0.84 (+4.03%)
Weekly Expected Move ±5.8%
$18
$19
$20
$21
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026169
Institutions Holding
+10 vs prior
89.1%
Ownership
+11.19%
28
New
52
Increased
70
Reduced
37
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | Raben David | officer: chief medical officer | S-Sale | 5,500 | $22.88 | $126K | Filing |
| 2026-04-21 | Hyep Ivan | officer: chief financial officer | S-Sale | 9,200 | $23.00 | $212K | Filing |
| 2026-04-20 | Mazumdar Claire | officer: chief executive officer | S-Sale | 15,000 | $23.61 | $354K | Filing |
| 2026-04-15 | Cohlhepp Ryan | officer: president and coo | S-Sale | 4,500 | $23.01 | $104K | Filing |
| 2026-04-15 | Cohlhepp Ryan | officer: president and coo | S-Sale | 8,000 | $23.01 | $184K | Filing |
| 2026-03-25 | Raben David | officer: chief medical officer | S-Sale | 5,500 | $18.95 | $104K | Filing |
| 2026-03-23 | Hyep Ivan | officer: chief financial officer | S-Sale | 9,200 | $18.52 | $170K | Filing |
| 2026-03-20 | Mazumdar Claire | officer: chief executive officer | S-Sale | 1,596 | $18.95 | $30K | Filing |
| 2026-03-19 | Mazumdar Claire | officer: chief executive officer | S-Sale | 6,905 | $18.78 | $130K | Filing |
| 2026-03-18 | Mazumdar Claire | officer: chief executive officer | S-Sale | 6,499 | $18.84 | $122K | Filing |
| 2026-03-16 | Cohlhepp Ryan | officer: president and coo | S-Sale | 4,500 | $19.66 | $88K | Filing |
| 2026-03-16 | Cohlhepp Ryan | officer: president and coo | S-Sale | 8,000 | $19.66 | $157K | Filing |
| 2026-03-06 | Mazumdar Claire | officer: chief executive officer | S-Sale | 3,817 | $18.75 | $72K | Filing |
| 2026-03-05 | Mazumdar Claire | officer: chief executive officer | S-Sale | 1,786 | $18.74 | $33K | Filing |
| 2026-03-04 | Mazumdar Claire | officer: chief executive officer | S-Sale | 2,631 | $18.73 | $49K | Filing |
| 2026-03-04 | Hyep Ivan | officer: chief financial officer | S-Sale | 2,963 | $18.25 | $54K | Filing |
| 2026-03-04 | Raben David | officer: chief medical officer | S-Sale | 16,300 | $18.52 | $302K | Filing |
| 2026-03-03 | Cohlhepp Ryan | officer: president and coo | S-Sale | 4,500 | $18.16 | $82K | Filing |
| 2026-03-03 | Cohlhepp Ryan | officer: president and coo | S-Sale | 12,892 | $18.16 | $234K | Filing |
| 2026-03-03 | Hyep Ivan | officer: chief financial officer | S-Sale | 13,555 | $18.22 | $247K | Filing |
| 2026-03-03 | Raben David | officer: chief medical officer | S-Sale | 200 | $18.45 | $4K | Filing |
| 2026-02-26 | RA Capital Nexus Fund III, L.P. | director | P-Purchase | 300,000 | $16.00 | $4.8M | Filing |
| 2026-02-26 | Shah Rajeev M. | director | P-Purchase | 300,000 | $16.00 | $4.8M | Filing |
| 2026-02-26 | RA Capital Healthcare Fund LP | director | P-Purchase | 300,000 | $16.00 | $4.8M | Filing |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | director | P-Purchase | 300,000 | $16.00 | $4.8M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7,255,993 | $144M | +300,000 | 2026-03-31 | Filing |
| Siren, L.L.C. | 5,802,970 | $115M | +586,001 | 2026-03-31 | Filing |
| Deep Track Capital, LP | 4,062,500 | $81M | +1,448,496 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 3,339,218 | $66M | +692,933 | 2026-03-31 | Filing |
| RED TREE MANAGEMENT, LLC | 3,170,509 | $63M | — | 2026-03-31 | Filing |
| TPG GP A, LLC | 3,010,425 | $60M | — | 2026-03-31 | Filing |
| BlackRock, Inc. | 2,843,707 | $57M | +315,256 | 2026-03-31 | Filing |
| Omega Fund Management, LLC | 2,392,150 | $48M | +187,500 | 2026-03-31 | Filing |
| Royalty Pharma Sub-Manager, LLC | 2,388,150 | $47M | +1,125,000 | 2026-03-31 | Filing |
| FMR LLC | 2,100,929 | $42M | -1,246,294 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,774,220 | $35M | +1,774,220 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 1,621,643 | $32M | +1,618 | 2026-03-31 | Filing |
| STATE STREET CORP | 1,419,388 | $28M | -230,149 | 2026-03-31 | Filing |
| Jones Hill Capital LP | 1,260,136 | $25M | +1,260,136 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 830,906 | $17M | +19,506 | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 667,300 | $13M | +458,200 | 2026-03-31 | Filing |
| ACORN CAPITAL ADVISORS, LLC | 643,382 | $13M | — | 2026-03-31 | Filing |
| Aisling Capital Management LP | 568,919 | $11M | — | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 558,964 | $11M | +6,633 | 2026-03-31 | Filing |
| Palo Alto Investors LP | 550,408 | $11M | +251,833 | 2026-03-31 | Filing |